John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$976M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$219M |
| 3 |
Humana
HUM
|
+$215M |
| 4 |
Pinterest
PINS
|
+$214M |
| 5 |
Snowflake
SNOW
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$301M |
| 2 |
Tesla
TSLA
|
+$254M |
| 3 |
Nike
NKE
|
+$248M |
| 4 |
Procter & Gamble
PG
|
+$233M |
| 5 |
Pfizer
PFE
|
+$232M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.09% |
| 2 | Financials | 10.23% |
| 3 | Consumer Discretionary | 10.17% |
| 4 | Healthcare | 10.17% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
The Joint Corp
JYNT
$120M
| $144K | ﹤0.01% |
14,979
-12,339
| -45% | -$107K |
|
|
KNDI
2852
Kandi Technologies Group
KNDI
$67.3M
| $143K | ﹤0.01% |
51,173
-16,808
| -25% | -$51.5K |
|
2853
RE/MAX Holdings
RMAX
$263M
| $142K | ﹤0.01% |
10,686
-22,017
| -67% | -$242K |
|
2854
Atossa Therapeutics
ATOS
$25.8M
| $142K | ﹤0.01% |
10,755
-841
| -7% | -$9.07K |
|
|
EMKR
2855
DELISTED
Emcore Corp
EMKR
| $141K | ﹤0.01% |
28,897
-3,391
| -11% | -$15K |
|
|
CBIO
2856
Crescent Biopharma
CBIO
$639M
| $141K | ﹤0.01% |
596
-545
| -48% | -$84.7K |
|
2857
Village Farms International
VFF
$350M
| $141K | ﹤0.01% |
184,763
+159,351
| +627% | +$122K |
|
2858
Tilray
TLRY
$656M
| $140K | ﹤0.01% |
+6,073
| New | +$117K |
|
|
JOBY.WS
2859
DELISTED
Joby Aviation Warrants
JOBY.WS
| $139K | ﹤0.01% |
113,659
| – | – |
|
|
EGIO
2860
DELISTED
Edgio, Inc. Common Stock
EGIO
| $137K | ﹤0.01% |
10,012
+3,048
| +44% | +$75.2K |
|
|
BFIN
2861
DELISTED
BankFinancial
BFIN
| $136K | ﹤0.01% |
13,270
-3,200
| -19% | -$29K |
|
|
LUMO
2862
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $136K | ﹤0.01% |
+42,619
| New | +$145K |
|
2863
Globalstar
GSAT
$10.6B
| $135K | ﹤0.01% |
4,647
-21,834
| -82% | -$480K |
|
2864
Spire Global
SPIR
$565M
| $134K | ﹤0.01% |
+17,156
| New | +$87.7K |
|
2865
Wave Life Sciences
WVE
$1.04B
| $134K | ﹤0.01% |
+26,543
| New | +$142K |
|
|
TCS
2866
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $133K | ﹤0.01% |
+3,891
| New | +$118K |
|
2867
Ribbon Communications
RBBN
$368M
| $133K | ﹤0.01% |
45,847
-65,462
| -59% | -$147K |
|
|
RAIN
2868
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $132K | ﹤0.01% |
110,347
-75,537
| -41% | -$81.5K |
|
|
CNTA
2869
DELISTED
Centessa Pharmaceuticals
CNTA
| $131K | ﹤0.01% |
16,500
+4,900
| +42% | +$32.9K |
|
|
BGFV
2870
DELISTED
Big 5 Sporting Goods
BGFV
| $130K | ﹤0.01% |
+20,478
| New | +$132K |
|
2871
1-800-Flowers.com
FLWS
$256M
| $127K | ﹤0.01% |
11,800
-16,900
| -59% | -$145K |
|
2872
Precigen
PGEN
$2.64B
| $126K | ﹤0.01% |
93,800
-10,200
| -10% | -$12K |
|
2873
Mama's Creations
MAMA
$769M
| $124K | ﹤0.01% |
+25,217
| New | +$99.5K |
|
2874
Rocket Lab Corp
RKLB
$43.2B
| $123K | ﹤0.01% |
22,300
| – | – |
|
2875
Karyopharm Therapeutics
KPTI
$43.3M
| $123K | ﹤0.01% |
+9,485
| New | +$128K |
|
Similar funds
John Overdeck's Q4 2023 Portfolio in Review
As of Q4 2023, John Overdeck held 3,484 positions worth $43.5B, up 17% from $37.2B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
John Overdeck's Q4 2023 filing shows 550 new, 1,237 increased, 1,116 reduced and 366 closed positions. Its largest new stake was Becton Dickinson: 732,254 shares worth $179M. The largest sale was Palantir, an estimated $301M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
- John Overdeck's largest Q4 2023 buy was Becton Dickinson: 732,254 shares worth $179M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $976M increase.
- John Overdeck's biggest Q4 2023 reduction was Palantir, cutting an estimated $301M.
- John Overdeck fully exited Tesla in Q4 2023, selling an estimated $254M.
- John Overdeck's ten largest holdings make up 9.3% of its $43.5B portfolio in Q4 2023.
- John Overdeck opened 550 new positions and closed 366 in Q4 2023.
- John Overdeck's portfolio value rose 17% quarter-over-quarter to $43.5B.
Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.